India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

The Department of Pharmaceuticals, Government of India, organised an Industry dialogue on the Promotion of Research and ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...